We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

122 hedge funds and large institutions have $380M invested in Cytokinetics in 2018 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 46 increasing their positions, 34 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 34

22% more capital invested

Capital invested by funds: $311M → $380M (+$69.1M)

1.52% more ownership

Funds ownership: 69.19% → 70.71% (+1.5%)

5% more call options, than puts

Call options by funds: $917K | Put options by funds: $875K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less funds holding

Funds holding: 126 → 122 (-4)

18% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 17

Holders
122
Holders Change
-4
Holders Change %
-3.17%
% of All Funds
2.79%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
46
Reduced
34
Closed
17
Calls
$917K
Puts
$875K
Net Calls
+$42K
Net Calls Change
+$182K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$6.05M
2
GPP
Great Point Partners
Connecticut
+$5.9M
3
Invesco
Invesco
Georgia
+$2.84M
4
SDIC
South Dakota Investment Council
South Dakota
+$1.46M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.29M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$2.92M
2
Millennium Management
Millennium Management
New York
-$1.87M
3
Goldman Sachs
Goldman Sachs
New York
-$1.13M
4
Allianz Asset Management
Allianz Asset Management
Germany
-$952K
5
PA
Pinnacle Associates
New York
-$875K
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
26
RhumbLine Advisers
Massachusetts
$1.22M +$32.4K +4,035 +3%
USAA
27
United Services Automobile Association
Texas
$1.22M -$14.3K -1,780 -1%
PAI
28
Palo Alto Investors
California
$1.22M – – –
CAM
29
ClariVest Asset Management
California
$1.2M -$27.3K -3,402 -3%
Legal & General Group
30
Legal & General Group
United Kingdom
$1.13M +$129K +16,053 +16%
Jacobs Levy Equity Management
31
Jacobs Levy Equity Management
New Jersey
$1.03M +$129K +16,038 +18%
IIM
32
Ironwood Investment Management
Massachusetts
$996K -$24.1K -3,005 -3%
TCIM
33
TIAA CREF Investment Management
New York
$955K -$34.4K -4,288 -4%
TA
34
Teachers Advisors
New York
$926K +$80.9K +10,081 +12%
Prudential Financial
35
Prudential Financial
New Jersey
$851K +$24.9K +3,100 +4%
Swiss National Bank
36
Swiss National Bank
Switzerland
$841K – – –
New York State Teachers Retirement System (NYSTRS)
37
New York State Teachers Retirement System (NYSTRS)
New York
$816K – – –
ASRS
38
Arizona State Retirement System
Arizona
$781K +$40.6K +5,057 +7%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$745K -$27.3K -3,400 -4%
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$698K +$3.73K +465 +0.7%
Two Sigma Advisers
41
Two Sigma Advisers
New York
$659K -$93.9K -11,700 -15%
Canada Life
42
Canada Life
Manitoba, Canada
$652K – – –
DCM
43
DAFNA Capital Management
California
$617K -$54.1K -6,747 -10%
Ohio Public Employees Retirement System (OPERS)
44
Ohio Public Employees Retirement System (OPERS)
Ohio
$612K -$91.6K -11,410 -16%
PPA
45
Parametric Portfolio Associates
Washington
$601K +$214K +26,651 +78%
AllianceBernstein
46
AllianceBernstein
Tennessee
$558K – – –
Barclays
47
Barclays
United Kingdom
$552K +$254K +31,669 +130%
VEA
48
Virtus ETF Advisers
New York
$493K -$287K -35,803 -42%
ERSOT
49
Employees Retirement System of Texas
Texas
$493K – – –
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$437K – – –
1
2
3 4 5

CYTK Hedge Fund Activity: Q3 2018 in Review

122 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q3 2018, worth a combined $380M — up 22% from $311M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of CYTK and 14 opened new positions — a net loss of 3 holders — while 34 trimmed existing stakes and 46 added.

The largest buyer was BlackRock, adding an estimated $6.05M. The largest seller was BVF Inc, cutting an estimated $2.92M.

  • 122 institutional investors held Cytokinetics (CYTK) as of Q3 2018, down from 126 in Q2 2018.
  • Funds reported $380M of Cytokinetics stock for Q3 2018, up 22% quarter-over-quarter.
  • 14 funds opened new Cytokinetics positions in Q3 2018 and 17 closed out, a net change of -3 holders.
  • The largest Cytokinetics buyer in Q3 2018 was BlackRock, an estimated $6.05M added.
  • The largest Cytokinetics seller in Q3 2018 was BVF Inc, an estimated $2.92M sold.

Based on aggregated 13F filings for Q3 2018.